272 related articles for article (PubMed ID: 22959964)
1. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Schreiber AK; Neufeld M; Jesus CH; Cunha JM
Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
[TBL] [Abstract][Full Text] [Related]
2. CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system.
Romero TR; Resende LC; Guzzo LS; Duarte ID
Anesth Analg; 2013 Feb; 116(2):463-72. PubMed ID: 23302980
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive effects of local injections of propofol in rats are mediated in part by cannabinoid CB1 and CB2 receptors.
Guindon J; LoVerme J; Piomelli D; Beaulieu P
Anesth Analg; 2007 Jun; 104(6):1563-9, table of contents. PubMed ID: 17513659
[TBL] [Abstract][Full Text] [Related]
4. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
5. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
Borsani E; Labanca M; Bianchi R; Rodella LF
Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
[TBL] [Abstract][Full Text] [Related]
6. Effects of the endocannabinoid transport inhibitors AM404 and UCM707 on diabetic neuropathy in rats.
Hasanein P; Soltani N
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1127-31. PubMed ID: 19413593
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
8. Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels.
Reis GM; Ramos MA; Pacheco Dda F; Klein A; Perez AC; Duarte ID
Life Sci; 2011 Apr; 88(15-16):653-7. PubMed ID: 21277864
[TBL] [Abstract][Full Text] [Related]
9. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain.
Guindon J; De Léan A; Beaulieu P
Pain; 2006 Mar; 121(1-2):85-93. PubMed ID: 16480822
[TBL] [Abstract][Full Text] [Related]
10. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
11. Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain.
Guindon J; Beaulieu P
Neuropharmacology; 2006 Jun; 50(7):814-23. PubMed ID: 16442133
[TBL] [Abstract][Full Text] [Related]
12. Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors.
de Morais H; de Souza CP; da Silva LM; Ferreira DM; Baggio CH; Vanvossen AC; Cristina de Carvalho M; da Silva-Santos JE; Bertoglio LJ; Cunha JM; Zanoveli JM
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1590-600. PubMed ID: 27544303
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of intrathecally administered AM404, an endocannabinoid reuptake inhibitor, on neuropathic pain in a rat chronic constriction injury model.
Haranishi Y; Hara K; Terada T
Pharmacol Rep; 2021 Jun; 73(3):820-827. PubMed ID: 33783763
[TBL] [Abstract][Full Text] [Related]
14. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain.
Costa B; Siniscalco D; Trovato AE; Comelli F; Sotgiu ML; Colleoni M; Maione S; Rossi F; Giagnoni G
Br J Pharmacol; 2006 Aug; 148(7):1022-32. PubMed ID: 16770320
[TBL] [Abstract][Full Text] [Related]
15. The antinociceptive effects of intraplantar injections of 2-arachidonoyl glycerol are mediated by cannabinoid CB2 receptors.
Guindon J; Desroches J; Beaulieu P
Br J Pharmacol; 2007 Mar; 150(6):693-701. PubMed ID: 17179944
[TBL] [Abstract][Full Text] [Related]
16. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
[TBL] [Abstract][Full Text] [Related]
17. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
18. α
Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG
Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857
[TBL] [Abstract][Full Text] [Related]
19. The Involvement of the Endocannabinoid System in the Peripheral Antinociceptive Action of Ketamine.
Ferreira RCM; Castor MGM; Piscitelli F; Di Marzo V; Duarte IDG; Romero TRL
J Pain; 2018 May; 19(5):487-495. PubMed ID: 29247851
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide.
Reis GM; Pacheco D; Perez AC; Klein A; Ramos MA; Duarte ID
Life Sci; 2009 Aug; 85(9-10):351-6. PubMed ID: 19576231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
